Use of Aspirin Associates with Longer Primary Patency of Hemodialysis Grafts

Extended-release dipyridamole plus low-dose aspirin (ERDP/ASA) prolongs primary unassisted graft patency of newly created hemodialysis arteriovenous grafts, but the individual contributions of each component are unknown. Here, we analyzed whether use of aspirin at baseline associated with primary un...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dixon, Bradley S., Beck, Gerald J., Dember, Laura M., Vazquez, Miguel A., Greenberg, Arthur, Delmez, James A., Allon, Michael, Himmelfarb, Jonathan, Hu, Bo, Greene, Tom, Radeva, Milena K., Davidson, Ingemar J., Ikizler, T. Alp, Braden, Gregory L., Lawson, Jeffrey H., Cotton, James R., Kusek, John W., Feldman, Harold I.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2011
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065232/
https://ncbi.nlm.nih.gov/pubmed/21415156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010060582
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars